Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Baxter International (NY: BAX)
69.46 USD  -1.01 (-1.43%)
Official Closing Price  /  Updated: 4:46 PM EDT, Oct 19, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 3,166,500
Open 70.65
Bid (Size) 68.01 (1)
Ask (Size) 85.85 (4)
Prev. Close 70.47
Today's Range 69.20 - 70.91
52wk Range 62.52 - 78.38
Shares Outstanding 535,485,895
Dividend Yield 0.96%
Performance
YTD
+3.41%
+3.41%
1 Month
-10.22%
-10.22%
3 Month
-7.31%
-7.31%
6 Month
+3.39%
+3.39%
1 Year
+8.33%
+8.33%
Top News
More News
Investor Expectations to Drive Momentum within Materion, Iridium Communications, Natural Health Trends, Revance Therapeutics, Baxter International, and Alexion Pharmaceuticals — Discovering Underlying
In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of Materion Corporation... Read More
from GlobeNewswire News Releases
Baxter to Showcase Critical Care Innovation at the 2018 European Society of Intensive Care Medicine Congress
Product innovations across Baxter’s Acute Therapies, Clinical Nutrition and Medication Delivery businesses to be featured at ESICM. Read More
from Business Wire News Releases
More News
Read More
Baxter and ASPEN Launch “SmartPN” Tools to Reinforce Appropriate Use of Parenteral Nutrition
from Business Wire News Releases
Baxter to Present at the 27th Annual Credit Suisse Healthcare Conference
from Business Wire News Releases
Baxter and Mayo Clinic Announce Collaboration to Establish Renal Care Center of Excellence in the U.S.
from Business Wire News Releases
Baxter Collaborates with University of Southern California Center for Body Computing to Advance Digital Health Solutions
from Business Wire News Releases
New Data on Floseal Surgical Hemostat Quantifies Clinical and Healthcare Resource Outcomes in Spine Surgery Cases
from Business Wire News Releases
Buy MedTech names due to improving fundamentals, Barclays says in sector initiation
category Medtronic PLC , Investing , Investment strategy , and 9 more.
from CNBC.com News
SPLV's Holdings Imply 12% Gain Potential
category ETFs
from ETF Channel
Baxter Announces U.S. FDA Clearance of ALTAPORE Bioactive Bone Graft in Posterolateral Spine Surgery
from Business Wire News Releases
Baxter Intl Inc Bearish Moving Average Crossover Alert (BAX)
from Comtex SmarTrend® News Briefs
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.